(Q40284731)

19 September 2017

title

Novel role of Stat1 in the development of docetaxel resistance in prostate tumor cells (English)

1 reference

19 September 2017

1 reference

1 reference

S G Patterson

1

1 reference

19 September 2017

S Wei

2

1 reference

19 September 2017

X Chen

3

1 reference

19 September 2017

D A Sallman

4

1 reference

19 September 2017

D L Gilvary

5

1 reference

19 September 2017

B Zhong

6

1 reference

19 September 2017

J Pow-Sang

7

1 reference

19 September 2017

T Yeatman

8

1 reference

19 September 2017

J Y Djeu

9

1 reference

19 September 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

25

1 reference

19 September 2017

issue

45

1 reference

19 September 2017

page(s)

6113-6122

1 reference

Constitutive activation of STAT proteins in the HDLM-2 and L540 Hodgkin lymphoma-derived cell lines supports cell survival.

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Chemotherapy in advanced androgen-independent prostate cancer 1990-1999: a decade of progress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

STATs and gene regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Chemotherapy: targeting the mitochondrial cell death pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Pathological and molecular mechanisms of prostate carcinogenesis: implications for diagnosis, detection, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Stat3 activation in prostatic carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Perturbed IFN-gamma-Jak-signal transducers and activators of transcription signaling in tuberous sclerosis mouse models: synergistic effects of rapamycin-IFN-gamma treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Overcoming multidrug resistance in taxane chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

The biochemistry of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Cellular stress response and apoptosis in cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Lack of association between enhanced TRPM-2/clusterin expression and increased apoptotic activity in sex-hormone-induced prostatic dysplasia of the Noble rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

STAT proteins and transcriptional responses to extracellular signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Apoptosis: a link between cancer genetics and chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Docetaxel (Taxotere) - an update.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Interleukin-6 protects LNCaP cells from apoptosis induced by androgen deprivation through the Stat3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Study of the effects of interferon a on several human hepatoma cell lines: analysis of the signalling pathway of the cytokine and of its effects on apoptosis and cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Chemistry and chemical biology of taxane anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Up-regulation of TRPM-2, MMP-7 and ID-1 during sex hormone-induced prostate carcinogenesis in the Noble rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Cancer epidemiology in the last century and the next decade

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

The current role of chemotherapy in metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Modulation of different clusterin isoforms in human colon tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

STAT-1: a novel regulator of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

STAT1: a modulator of chemotherapy-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Clusterin/apolipoprotein J in human aging and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Regulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Overexpression of the cytoprotective protein clusterin decreases radiosensitivity in the human LNCaP prostate tumour model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Clusterin Has Chaperone-like Activity Similar to That of Small Heat Shock Proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

Clinical and biomarker correlates of androgen-independent, locally aggressive prostate cancer with limited metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

7 January 2021

Stat3 enhances the growth of LNCaP human prostate cancer cells in intact and castrated male nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

7 January 2021

Immune selection and emergence of aggressive tumor variants as negative consequences of Fas-mediated cytotoxicity and altered IFN-gamma-regulated gene expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

7 January 2021

Hormonal therapy for prostate cancer: primum non nocere

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1209632

1 reference

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1209632

1 reference

Dimensions Publication ID

19 September 2017

1025903837

0 references

1 reference